Monte Rosa Therapeutics
GLUE
GLUE
125 hedge funds and large institutions have $445M invested in Monte Rosa Therapeutics in 2025 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
18% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 40
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
53% less call options, than puts
Call options by funds: $1.84M | Put options by funds: $3.9M
Holders
125
Holding in Top 10
2
Calls
$1.84M
Puts
$3.9M
Top Buyers
| 1 | +$5.93M | |
| 2 | +$5.15M | |
| 3 | +$3.88M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$3.38M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.03M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$12.5M | |
| 3 | -$4.2M | |
| 4 |
Goldman Sachs
New York
|
-$1.83M |
| 5 |
Renaissance Technologies
New York
|
-$1.63M |
